Peripheral nerve injury increases glutamate-evoked calcium mobilization in adult spinal cord neurons

  • Suzanne Doolen1,

    Affiliated with

    • Camille B Blake1,

      Affiliated with

      • Bret N Smith1 and

        Affiliated with

        • Bradley K Taylor1Email author

          Affiliated with

          Molecular Pain20128:56

          DOI: 10.1186/1744-8069-8-56

          Received: 30 May 2012

          Accepted: 5 July 2012

          Published: 28 July 2012

          Abstract

          Background

          Central sensitization in the spinal cord requires glutamate receptor activation and intracellular Ca2+ mobilization. We used Fura-2 AM bulk loading of mouse slices together with wide-field Ca2+ imaging to measure glutamate-evoked increases in extracellular Ca2+ to test the hypotheses that: 1. Exogenous application of glutamate causes Ca2+ mobilization in a preponderance of dorsal horn neurons within spinal cord slices taken from adult mice; 2. Glutamate-evoked Ca2+ mobilization is associated with spontaneous and/or evoked action potentials; 3. Glutamate acts at glutamate receptor subtypes to evoked Ca2+ transients; and 4. The magnitude of glutamate-evoked Ca2+ responses increases in the setting of peripheral neuropathic pain.

          Results

          Bath-applied glutamate robustly increased [Ca2+]i in 14.4 ± 2.6 cells per dorsal horn within a 440 x 330 um field-of-view, with an average time-to-peak of 27 s and decay of 112 s. Repeated application produced sequential responses of similar magnitude, indicating the absence of sensitization, desensitization or tachyphylaxis. Ca2+ transients were glutamate concentration-dependent with a Kd = 0.64 mM. Ca2+ responses predominantly occurred on neurons since: 1) Over 95% of glutamate-responsive cells did not label with the astrocyte marker, SR-101; 2) 62% of fura-2 AM loaded cells exhibited spontaneous action potentials; 3) 75% of cells that responded to locally-applied glutamate with a rise in [Ca2+]i also showed a significant increase in AP frequency upon a subsequent glutamate exposure; 4) In experiments using simultaneous on-cell recordings and Ca2+ imaging, glutamate elicited a Ca2+ response and an increase in AP frequency. AMPA/kainate (CNQX)- and AMPA (GYKI 52466)-selective receptor antagonists significantly attenuated glutamate-evoked increases in [Ca2+]i, while NMDA (AP-5), kainate (UBP-301) and class I mGluRs (AIDA) did not. Compared to sham controls, peripheral nerve injury significantly decreased mechanical paw withdrawal threshold and increased glutamate-evoked Ca2+ signals.

          Conclusions

          Bulk-loading fura-2 AM into spinal cord slices is a successful means for determining glutamate-evoked Ca2+ mobilization in naïve adult dorsal horn neurons. AMPA receptors mediate the majority of these responses. Peripheral neuropathic injury potentiates Ca2+ signaling in dorsal horn.

          Keywords

          Pain AMPA receptor Central sensitization Calcium imaging

          Background

          Central sensitization is a glutamate receptor-dependent increase in the excitability of neurons within the central nervous system, and is thought to contribute to enhanced responsiveness to sensory input following tissue injury [1]. After nerve injury, damaged and non-damaged peripheral afferents generate spontaneous action potentials (AP) within nociresponsive neurons within the dorsal horn [2]. Glutamate, released from pre-synaptic terminals in an activity-dependent manner, binds post-synaptic ionotropic and metabotropic receptors, leading to intracellular Ca2+ mobilization [1, 3, 4]. The resulting calcium-induced activation of intracellular kinases can then phosphorylate several residues on the C-terminus of NMDA and AMPA receptors; these post-translational modifications, together with increased receptor trafficking to and from the membrane and increased responsiveness to glutamate, are thought to contribute to the functional changes that manifest as central sensitization [57]. Despite the importance of Ca2+ mobilization to the central sensitization that drive neuropathic pain, however, few studies have investigated real-time [Ca2+ i responses in populations of dorsal horn neurons [8, 9].

          While patch-clamp recording allows sampling of single neurons, the bulk-loading of Ca2+-sensitive indicator dyes enables simultaneous recording across populations of dorsal horn cells. However, previous studies describing bulk-loaded Ca2+ imaging in spinal cord slices have not fully discriminated between neuronal and glial responses [810]. One obstacle is that both neurons and astrocytes exhibit glutamate-evoked Ca2+mobilization in the CNS [11, 12]. To overcome this obstacle in our spinal cord slice imaging studies, we employed the fluorescent dye SR-101, a specific marker of astroglia in the CNS [13, 14].

          Behavioral pharmacology studies support the contribution of spinal glutamatergic and Ca2+ channel signaling to the development and/or maintenance of allodynia and hyperalgesia [1518]. For example, it is well-known that intrathecal AMPA- and NMDA-receptor antagonist administration attenuates pain-like behavior in models of neuropathic pain [1519]. Furthermore, convergent observations obtained in a variety of pain models indicate that intrathecal administration of antagonists to N- and T-type voltage-gated calcium channels (VGCC) produce anti-allodynic effects, with smaller effects after injection of P/Q- and L-type channel blockers [2026]. While these studies implicate glutamate receptors and Ca2+ signaling in central sensitization and neuropathic pain, the underlying cellular mechanisms are poorly understood. In this study, we show that glutamate-evoked Ca2+ signals in adult dorsal horn neurons are mediated predominantly by AMPA channels and are potentiated by peripheral neuropathic injury.

          Results

          Glutamate-evoked Ca2+ mobilization in adult dorsal horn neurons

          To determine whether exogenous application of glutamate causes Ca2+ mobilization in a preponderance of lamina II dorsal horn cells of adult mice, we conducted Fura-2 Ca2+ imaging within transverse spinal cord slices. Spontaneous calcium waves were not observed, consistent with previous reports in 11–15 day-old mice [10]. Within a 440 x 330 um field-of-view in 9 dorsal horn slices, we observed an average of 15 ± 1 Fura-2 loaded cells. Imaged cells were located less than 35 um below the tissue surface. Glutamate superfusion (1 mM, 10 s) evoked Ca2+ transients in 93% (14 ± 2) cells (Figure 1 and Table 1). Glutamate increased [Ca2+ i with an average time-to-peak and duration (from onset to return to 20% of peak) of approximately 27 s and 139 s, respectively.
          http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-56/MediaObjects/12990_2012_Article_509_Fig1_HTML.jpg
          Figure 1

          Calcium imaging in adult mouse spinal cord slices. Ratiometric images of dorsal horn before ( A) and during ( B) a 10 s exposure to 1 mM glutamate. Pseudocolor images show values of the 340/380 ratio where blue indicates basal Ca2+ levels and green/red indicate a glutamate-evoked Ca2+ increase. C. Glutamate-evoked Ca2+ traces evoked in panels A and B. The red trace represents an SR-101 positive cell indicated by the red arrowhead in A and B and the green traces represent SR-101 negative cells indicated by green arrows. Numbers on green arrows correspond to numbered traces in panel C. D. Numerous cells bulk loaded with Fura-2 AM are indicated by white arrowheads. A double-labeled astrocytic cell is indicated by a red arrowhead. E. Astrocyte labeling pattern with SR-101 in the same adult spinal cord slice. F. Merged image shows that the majority (~95%) of Fura-2 AM loaded cells are non-astrocytic.

          Table 1

          SR-101 labeling and action potentials in cells that respond to glutamate with an increase in [Ca 2+ ] i

          # cells exhibiting glutamate-evoked increase [Ca 2+] i

          SR-101 positive cells

          Double labeled cells

          % Double labeled cells

          130 (14 ± 2.6)

          149 (16 ± 1.8)

          6 (1 ±0.23)

          4.36 ± 1.4

          # cells exhibiting glutamate-evoked increase [Ca 2+ ] i

          # cells exhibiting Spontaneous AP

          %

          29

          18

          62.1

           

          # cells exhibiting glutamate-evoked AP

          %

          20

          15

          75

          Data represent total cell counts. Average ± SEM per slice shown in parenthesis are from 9 slices from 9 different animals.

          Both CNS neurons and astrocytes respond to glutamate with intracellular Ca2+ mobilization [11, 12]. To discriminate the two cell types, we used real-time double-labeling with fura-2 and SR-101. Previous studies indicate that incubation of brain slices with SR-101 specifically labels astrocytes for at least 8 h [13, 14]. As illustrated in Figure 1 and Table 1, SR-101 labeled 16 ± 1.8 cells within a 440 x 330 um field-of-view in the dorsal horn (n = 9 views). Of the 130 glutamate-responsive cells, 4 ± 1.4% (6 cells) were labeled with SR-101. Of the SR-101 positive cells, only a small proportion, 4 ± 1.7%, were glutamate responsive. These data suggest that the vast majority of glutamate-responsive cells are SR-101 negative, and thus likely represent non-astrocytic cells.

          To further test the hypothesis that glutamate-evoked Ca2+ responses in spinal cord slices occur primarily in neurons, we conducted experiments to concurrently assess Ca2+ mobilization and electrophysiological responses to glutamate. We evaluated whole-cell recordings in 29 fura-2 loaded cells. Spontaneous APs were observed in 18 neurons (62.1%), with an average firing frequency of 2.97 ± 0.63 Hz. We found 20 cells that responded to a brief pulse of glutamate with a [Ca2+]i increase (at least 10% above baseline). Of these, 15 (75%) exhibited a significant increase in AP frequency upon a subsequent glutamate exposure (from 3.0 ± 6 Hz in ACSF to 29.0 ± 8.7 Hz after glutamate, p < 0.01, n = 15; paired t-test). Figure 2A shows that glutamate caused a transient increase in AP firing.
          http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-56/MediaObjects/12990_2012_Article_509_Fig2_HTML.jpg
          Figure 2

          Glutamate-evoked Ca 2+ response and APs in DH neurons. A. Electrophysiological responses to glutamate are also repeatable. Whole cell recording from slices prepared from a post-natal day 13 mouse shows current responses to glutamate (50 mM; 200 ms). B. Ca2+ response to glutamate (50 mM; 50 ms pulse). Inset: Fluorescent images taken with excitation at 340 nm before (left) and during exposure to glutamate (right). Scale bar: 10 um. C. Simultaneous on-cell recording indicates glutamate-evoked AP currents concurrently with Ca2+ response. Inset: Left: AP frequency over time. Right: Enlarged view showing generation of AP currents. *** P < 0.0001.

          On-cell recording allows for simultaneous electrophysiological recording and Ca2+ imaging because it employs a GΩ seal without rupturing the cell and allowing intracellular fura-2 to diffuse into the recording pipette. As illustrated in Figure 2B, experiments using simultaneous on-cell recordings and Ca2+ imaging, Ca2+ responses to glutamate were accompanied an increase in AP frequency. For both whole-cell and on-cell recordings, glutamate-evoked AP burst after focal glutamate application onset was rapid (2.54 ± 1.0 s), corresponding temporally with the Ca2+ rise. Action potential bursts (1.02 ± 0.38 s; n = 15) were typically of shorter duration than the corresponding Ca2+ response (34.03 ± 10.26 s) (Figure 3). To further characterize [Ca2+]i responses, we administered glutamate repeatedly and at varying concentrations. As illustrated in Figure 3A, repeated superfusion with glutamate (1 mM for 10 s at 10 min intervals) produced sequential responses of similar magnitude (F(5,18) = 0.43, p = 0.82), indicating the absence of sensitization, desensitization or tachyphylaxis.
          http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-56/MediaObjects/12990_2012_Article_509_Fig3_HTML.jpg
          Figure 3

          Calcium responses elicited by glutamate. ( A.- B.) Average peak Ca2+ responses are repeatable and concentration dependent. Slices prepared from 4–6 wk CD-1 mice were superfused with aCSF at 1 ml/min. Scale bar: horizontal, Δ340/380 = 0.1; vertical, time = 60 s. Data represent average ± SEM. A. Representative tracings and average peak Ca2+ responses to 10-s pulses of 1 mM glutamate spaced at 10 min intervals. Glutamate elicited repeatable [Ca2+]i transients. N = 4 slices. B. Representative tracings and average peak Ca2+ responses to increasing glutamate concentrations. N = 3 slices.

          Glutamate receptor pharmacology

          AMPAR, NMDAR and kainate receptor (KAR), as well as metabotropic (mGluRs, groups I–III) glutamate receptors are densely expressed in the dorsal horn and contribute to the initiation and maintenance of central sensitization [1, 3, 2737].To confirm that glutamate acted through a receptor-dependent mechanism, we first evaluated [Ca2+ i responses to increasing glutamate concentrations. As illustrated in Figure 3B, the magnitude of glutamate-evoked increases in [Ca2+ i was concentration–dependent, with an ED50 = 0.64 mM.

          To investigate which ionotropic receptor subtype(s) contribute to glutamate-evoked Ca2+ responses, spinal cord slices were pre-incubated with selective receptor antagonists. The repeatability of glutamate responses allowed for a simple, within-subject design involving glutamate application followed by antagonist administration prior to and during a second glutamate application. Ca2+ transients in response to glutamate in the presence of increasing concentrations of the AMPA/kainate receptor antagonist CNQX are shown in Figure 4A. CNQX attenuated glutamate-evoked Ca2+ transients in a concentration-dependent manner with an IC50 = 6.5 μM. The highest concentration tested (200 μM) produced an 83.1 ± 2.9% reduction (Figure 4B; F(4,13) = 8.33, p < 0.01). Similarly, GYKI 52466, a selective AMPA receptor antagonists, attenuated glutamate-evoked Ca2+ transients with an IC50 = 6.1 μM. The maximal effect of GYKI 52466 observed at 100 μM was 56.7% (Figure 4C; F(4,30) = 4.25, p < 0.01). By contrast, the kainate-selective antagonist UBP-301 did not significantly attenuate glutamate-evoked Ca2+ responses (Figure 4D; F(2, 18) = 0.89, p = 0.42). Neither did UBP-310, another selective kainate antagonist (p > 0.05, data not shown). AP-5, an NMDA-selective antagonist, also did not change glutamate-evoked Ca2+ responses (Figure 4E; F(4, 26) = 1.78, p = 0.34).
          http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-56/MediaObjects/12990_2012_Article_509_Fig4_HTML.jpg
          Figure 4

          Effect of sub-type selective antagonists on glutamate-evoked Ca 2+ responses. Slices prepared from 4–6 wk CD-1 mice were superfused with aCSF at 1 ml/min. A. Representative Ca2+ traces from dorsal horn cell in response to 1 mM glutamate in the presence of increasing concentrations of CNQX. The last trace is after a final washout, indicating that the tissue is still viable and responsive to glutamate. B, CNQX (3–6 slices); C, GYKI 52466 (4–14 slices); D, UBP-301 (3 slices); E, AP-5 (4–11 slices); F, AIDA, (3–8 slices). Antagonists were present for 10 min prior, as well as during glutamate-evoked stimulation. Data represent average ± SEM. *P < 0.05.

          In addition to evoking Ca2+ influx through ionotropic glutamate receptors, glutamate can activate group I metabotropic receptors. Group I mGluRs couple to Gq/11 [38] and mobilize Ca2+ release from intracellular stores while group II and III couple to Gi/o. Although group I receptors do not participate in basal nociception, their activation is necessary for activity-dependent central sensitization [3944]. As illustrated in Figure 4F, however, the group I metabotropic glutamate receptor antagonist AIDA (up to 500 μM) did not significantly change Ca2+ responses as compared to vehicle (F(3,15) = 2.14, p = 0.13).

          Glutamate-evoked Ca2+ mobilization in neuropathic injury

          Behavioral pharmacology studies support the contribution of glutamatergic and Ca2+ channel signaling to the development and/or maintenance of neuropathic pain [1519]. To test the hypothesis that peripheral nerve injury potentiates glutamate-evoked Ca2+ responses in a manner that coincides with neuropathic pain-like behavior, we first evaluated tactile sensitivity prior to, 1d, 3d and 7d following Sham or SNI surgery. Figure 5A illustrates the development of mechanical hyperalgesia at 7 days post-SNI surgery. The force required to elicit hindpaw withdrawal decreased from a pre-surgical mean baseline value of 3.5 ± 1.1 to a much lower value on day 7 after SNI of 0.1 ± 0.04. Thus, compared to sham controls, SNI significantly reduced hindpaw withdrawal threshold (F(2,40) =4.66, p < 0.05). We next evaluated the glutamate dose-response relationship of peak Ca2+ signals in slices obtained 7–10 days after surgery, (Figure 5B). Compared to Sham, SNI produced significantly greater glutamate-evoked Ca2+ signals (F(1,11) = 9.8, p < 0.05). Bonferroni post-hoc analysis found this difference to be significant at all concentrations above 0.03 mM.
          http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-56/MediaObjects/12990_2012_Article_509_Fig5_HTML.jpg
          Figure 5

          Effect on peripheral nerve injury on glutamate-evoked Ca 2+ transients. A. Development of mechanical hyperalgesia following SNI. Withdrawal threshold of the ipsilateral hindpaws to mechanical stimulation with von Frey hairs in SNI mice are compared to those of sham-operated mice. B. Peak glutamate-evoked Ca2+ responses in dorsal horn slices from sham and neuropathic (SNI) mice. Slices were prepared from 5 wk mice 7–10 d after sham or SNI surgery. Ca2+ responses were evoked by a 10 s exposure to glutamate at concentrations indicated. Data represent average ± SEM from 5 slices. *P < 0.05.

          Discussion

          The present study characterizes glutamate-evoked Ca2+ mobilization in adult dorsal horn and its modulation by neuropathic injury. For the first time, we report simultaneous Ca2+ imaging of multiple neurons in adult mouse spinal cord slices using real-time imaging of Fura-2 and SR 101. Our results reflect an assay in which glutamate predominantly evokes Ca2+ signals in neurons, and indicated that this is largely mediated by AMPA receptors. Our results indicate that SNI potentiates Ca2+ signaling and may lead to spinal cord central sensitization and neuropathic pain.

          Glutamate superfusion evokes repeatable, concentration-dependent Ca2+ mobilization in the dorsal horn of adult spinal cord slices

          In vitro spinal cord slice studies of pain transmission most commonly use tissues obtained from neonatal rodents [10, 45, 46]. Since AMPA subunit mRNA levels [47] and both NMDA and AMPA receptor subunit protein expression in the spinal cord are high during development and decline until 4 weeks of age [48] plasticity in response to neuropathic or inflammatory insult is not clear. We chose to study the mechanisms responsible for Ca2+ signaling in adults because glutamate signaling in rodents is not mature until 4 wk of age [4753]. It is also important to characterize Ca2+ mobilization in adult spinal cord since many animals models of pain take many weeks to establish.

          A previous Ca2+ imaging study in transverse slices from adult spinal cord indicated that imaging was unsatisfactory in slices from animals older than 15 days [10, 54], perhaps due to poor fura-2 uptake into the tissue. However, with the use of ice cold transcardial perfusion with aCSF containing kynurinic acid, rapid spinal cord isolation, and a slicer with minimal advance speed and minimal blade deflection, we were able to elicit glutamate-evoked [Ca2+ i increases in nearly all fura-2 loaded cells from young adult animals. Furthermore, the magnitude of [Ca2+ i responses was concentration-dependent, and sustained with repeated applications of glutamate. These results indicate superb tissue health of our slice preparation, and demonstrate access of the cells to the superfusion fluid.

          Glutamate concomitantly evoked APs and robust increases in [Ca2+ i. The Ca2+ response peaked at approximately 30 sec and typically lasted 2–3 minutes, consistent with the temporal profile of [Ca2+ i increase following NMDA superfusion in Fura-2-injected single cells of 18–30 d old spinal cord slices [55]. By contrast, the duration of neuronal firing during the glutamate puff application lasted about 1 second. This most likely resulted from inactivation of Na+-dependent APs caused by the continued and strong depolarization of the neurons by glutamate. Our whole-cell voltage tracings suggest that the glutamate-dependent depolarization persisted even after sodium channels were inactivated. This sustained depolarization may reflect or contribute to the substantial Ca2+ mobilization following glutamate stimulation, which takes several minutes to return to basal [Ca2+ i levels. Further experiments will be necessary to determine the relative contribution of APs and VGCC opening, Ca2+ entry through glutamate receptors, or intracellular Ca2+ release from stores to the glutamate-evoked [Ca2+ i rise.

          Glutamate-evoked Ca2+ mobilization occurs predominantly in neurons

          Sandkuhler and colleagues were the first to describe Ca2+ responses in adult transverse spinal cord slices pre-loaded with fura-2 [8]. Both neurons and astrocytes exhibit glutamate-evoked calcium mobilization in the CNS [11, 12, 56]. Sandkuhler and colleagues defined a Ca2+ response to be neuronal if it peaked within 1 s of stimulus initiation, and its amplitude exceeded ten times baseline noise [8]. They also stated that patch-clamp recordings from fura-2-loaded dorsal horn cells suggested responses to be neuronal; however, they did not present data confirming this finding [8]. Because more recent studies indicate that mechanical sensory stimulation can elicit Ca2+ transient peaks in astrocytes within 0.5 s [57], we sought more direct evidence indicating that Ca2+ responses to glutamate occur predominantly in neurons. First, we found that less than 5% of glutamate-responsive cells were labeled with the astrocyte marker, SR-101. This is consistent with recent in vivo studies from the hindlimb area of the mouse primary somatosensory cortex, which demonstrated that ~5% of SR-101 labeled astrocytes exhibit Ca2+ transients in response to mechanical hindlimb stimulation [57]. On the other hand, ~80% of SR101 cells were stained with fluo-4 AM in juvenile hippocampal slices from rats [58]. Different cell types in CNS tissue slices acquire Ca2+-sensitive dyes with different efficiency, presumably as a result of variability in cellular surface-to-volume ratio [59]. We speculate that, in our spinal cord slice preparation, fura-2 is particularly facile at crossing the neuronal membrane.

          A second piece of evidence indicating that Ca2+ responses predominantly occur on neurons is our electrophysiological data, which suggests that the majority of fura-2 loaded cells are excitable. For example, 62% of fura-2 loaded cells exhibited spontaneous APs and 75% of cells that responded to glutamate with a rise in [Ca2+]i also showed a significant increase in AP frequency upon a subsequent glutamate exposure. In experiments using simultaneous AP recordings and Ca2+ imaging, glutamate elicited a Ca2+ response and an increase in AP frequency. We conclude that, since the majority of glutamate-responsive fura-2 loaded cells are non-astrocytic and are electrically excitable, neurons make up the majority of responsive cells.

          Glutamate-evoked Ca2+ mobilization is predominantly driven by AMPA receptor activation

          The AMPA/kainite and AMPA receptor-selective antagonists CNQX and GYKI 52466 substantially inhibited glutamate-evoked increases in [Ca2+ i, while kainate-, NMDA-, and metabotropic class I- selective antagonists did not. These data suggest that in dorsal horn of adult mice, AMPA receptors are sufficient to drive glutamate-evoked Ca2+ signaling, either directly or by eliciting APs, which activate VGCCs. This is not surprising because at resting conditions the NMDA receptor channel pore is blocked by Mg2+ [60]. This contrasts with results obtained in spinal cord slices from juvenile mice where both NMDA and AMPA receptors contribute to Ca2+ mobilization in response to dorsal root stimulation [10]. One explanation for these disparate findings is that, relative to neonate, adult NMDA receptors play a relatively small role in glutamate-evoked Ca2+ mobilization. More specifically, NR2B mRNA is present in lamina II during embryonic development through adulthood [61]. The NR2B subunit is characterized by a relatively strong Mg2+ block [52], and therefore AMPA contribution may not be sufficient to relieve the Mg2+ block from NMDA receptors in adult slices. Conversely, the NR2D subunits that are highly expressed in dorsal horn at P1 and P7 (but absent by P14) [61], are characterized by a relatively weak Mg2+ block [52], and therefore AMPA contribution would be sufficient to relieve the Mg2+ block from NMDA receptors in juvenile slices. A second possible explanation is that the dorsal root stimulation used in the juvenile slice studies provides synaptically localized glutamate release that is sufficient to activate NMDA receptors, whereas our concentrations of superfused glutamate do not reach sufficiently high concentrations to elicit NMDA receptor activation. Indeed, we found that the AP-5 produced a trend towards inhibition of glutamate-evoked Ca2+ response, which is similar to the small 20% decrease observed in the setting of dorsal root stimulation [55].

          Possible mechanisms by which the AMPA receptor contributes to glutamate-evoked Ca2+ mobilization include depolarization-induced expulsion of the NMDA Mg2+ block, thus allowing Ca2+ entry through the NMDA receptor [62]. Alternatively, Ca2+ may enter the pore of calcium-permeable AMPA receptors. Agonist-induced cobalt-uptake, a surrogate marker for agonist-induced calcium influx, has revealed a high density of Ca2+-permeable AMPA receptors in the spinal dorsal horn, particularly in superficial laminae [63]. Activation of AMPA receptors can also induce APs. Since glutamate most often resulted in AP generation in dorsal horn neurons, the depolarization, consequent opening of VGCCs, and subsequent Ca2+ flux is a likely contributor to the Ca2+ mobilization we observed.

          Our findings that class I mGlu receptors do not contribute to Ca2+ mobilization is in agreement with previous studies [10]. Previous studies also support our finding that kainate receptors do not contribute to Ca2+ mobilization: although kainate receptors on DRG neurons are predominantly Ca2+-permeable in late embryonic and newborn rats, they become fully Ca2+-impermeable later in the first postnatal week [34]. While these data suggest that kainate and class I mGlu receptors do not contribute to Ca2+ mobilization in naïve animals, they do not rule out the possibility that they contribute to central sensitization after nerve injury [3944, 64].

          Neuropathic injury potentiates glutamate-evoked Ca2+ mobilization

          Our studies demonstrate that nerve injury produced mechanical hypersensitivity and potentiated glutamate-evoked Ca2+ mobilization in adult dorsal horn neurons. These data are consistent with behavioral pharmacology studies supporting the contribution of glutamatergic and Ca2+ channel signaling to the development and/or maintenance of neuropathic pain [1518]. By what mechanism does SNI potentiate glutamate evoked increases in [Ca2+ i? We present several possibilities. 1) One possible mechanism is that injury-induced afferent activity might drive the entry of Ca2+ through NMDA channels. After peripheral nerve injury, damaged and uninjured A- and C-fibers begin to generate spontaneous APs, leading to the release of primary afferent neurotransmitters [2]. Slow depolarization induced by peptides such as substance P may then lead to expulsion of Mg2+ block, allowing for NMDA channel opening and Ca2+ entry upon glutamate stimulation [65]. 2) A second possible explanation is that injury-induced activation of kinases may lead to the phosphorylation and subsequent alteration of NMDA and/or AMPA receptors. For example, upon noxious stimulation, PKA phosphorylates GluR1 subunits, causing insertion of these receptors into the post-synaptic membrane, thus leading to an increase in synaptic strength [31, 66, 67]. Also, noxious stimuli cause phosphorylation of NMDA NR1 subunits by PKA or PKC, leading to enhanced response to glutamate. [6871]. 3) A third mechanism is that SNI increases mGluR activation of Gq/11 thus leading to increased Ca2+ mobilization. Peripheral inflammation causes trafficking of group I mGluRs to the plasma membrane in the spinal dorsal horn neurons [36] and behavioral studies indicates a greater response to group I mGluR agonists in CCI compared to control, suggesting that group I mGluRs contribute to neuropathic pain [72]. 4) A fourth possible mechanism is that SNI induced a switch from GluR2-containing to GluR2-lacking AMPARs; this would allow for increased Ca2+ entry through the AMPA receptor pore. Ca2+ permeability is modified not only by neuronal activity, but also by changes in expression, trafficking post-translation changes of AMPAR subunits [73, 74]. Studies using inflammatory pain models indicate activity-dependant GluR1 expression on the cell membrane and GluR2 internalization [75, 76]. 5) A fifth possible mechanism is that astrocytic Ca2+ elevations induce NMDA receptor-mediated slow inward currents (SICs) and Ca2+ elevations in neurons, leading to pain sensitization. Experimentally induced stimuli that trigger Ca2+ mobilization in astrocytes (low Ca2+, BzATP) induce NMDA receptor-mediated SICs in neurons in the rat dorsal horn, and these SICs are significantly increased by inflammatory injury [77]. Our finding that glutamate induces Ca2+ elevations in a subset of astrocytes support the presence of this mechanism in dorsal horn. 6) A sixth, more general mechanism is that injury increases the electrophysiological properties of the post-synaptic neurons. While chronic sciatic constriction in rat did not change resting membrane potential, response threshold, or input resistance, it did increase the amplitude and frequency of subthreshold synaptic currents in a subset of lamina II neurons [78]. Ultimately, one or more likely several of these mechanisms could increase neuronal Ca2+ mobilization, a critical step to central sensitization.

          Methods

          Animals

          Adult male CD-1 mice (4–8 weeks old) were housed 4 per cage in a temperature controlled (68-72  F) room on a 14:10 hour light/dark cycle (dark hours from 8 PM-6 AM), and were given food and water ad libitum. Animal use protocols were approved by the Institutional Animal Care and Use Committee of the University of Kentucky.

          Preparation of adult mouse spinal cord slices

          Mice were anesthetized with 5% isoflurane and quickly perfused transcardially with 10 ml of ice-cold sucrose-containing artificial cerebrospinal fluid (aCSF) (sucrose-aCSF) that contained (in mM): NaCl 95, KCl 1.8, KH2PO4 1.2, CaCl2 0.5, MgSO4 7, NaHCO3 26, glucose 15, sucrose 50 kynurenic acid 1, oxygenated with 95% O2, 5% CO2; pH 7.4. The lumbar spinal cord was rapidly (within 90s) isolated by laminectomy from the cervical enlargement to the cauda equina, placed in oxygenated ice-cold sucrose-aCSF, cleaned of dura mater and ventral roots, and super-glued vertically to a block of 4% agar (Fisher Scientific, Pittsburgh, PA) on the stage of a Campden 5000mz vibratome (Lafayette, IN). Transverse slices (300–450 um) from lumbar segments L4-L5 were cut in ice-cold sucrose-aCSF using minimum forward speed ranging from 0.03 to 1 mm/s and using maximum vibration. The ideal total dissection and slicing time to insure slice viability was 22 minutes or less.

          Fluorometric Ca2+ measurements

          Slices were incubated for 60 min at room temperature with Fura-2 AM (10 μM), pluronic acid (0.1%) in oxygenated aCSF containing (in mM): NaCl 127, KCl 1.8, KH2PO4 1.2, CaCl2 2.4, MgSO4 1.3, NaHCO3 26, glucose 15, followed by a 20 min de-esterification period in normal aCSF. Prior to recording, slices were kept at RT in a chamber containing approximately 150 ml of oxygenated aCSF. In some studies, prior to incubation in fura-2, slices were incubated for 20 min at 34  C in 1 μM SR-101 in normal aCSF, as previously described [14].

          Slices were perfused at 1–2 ml/min with normal aCSF in an RC-25 recording chamber (Warner Instruments, Hamden, CT) mounted on a Nikon FN-1 upright microscope fitted with a 79000 ET FURA2 Hybrid filter set (Nikon Instruments, Melville, NY) and a Photometrics CoolSNAP HQ2 camera (Tucson, AZ). Relative intracellular Ca2+ levels were determined by measuring the change in ratio of fluorescence emission at 510 nm in response to excitation at 340 and 380 nm (200 ms exposure). Paired images were collected at 1–1.5 seconds/frame. Relative changes in Ca2+ levels were evaluated using Nikon Elements software by creating a region of interest over the cell body and calculating the peak change in ratio. The peak magnitude of Ca2+ transient was expressed as difference in (ratio x 100) exposure to exogenous glutamate compared to baseline before glutamate. The criteria for a Ca2+ response were considered at least 10% increase above the baseline ratio. Ca2+ transients were in response to a 10 s exposure to 1 mM glutamate unless indicated otherwise. In antagonist studies, the slice was perfused with the antagonist for 10 min prior to and during glutamate stimulation. Only cells that displayed a consistent control response to 1 mM glutamate at the beginning and end of the experiment (showing a less than 40% decrease in glutamate-evoked Ca2+ transients) of were included in this study.

          Electrophysiology

          Cell-attached and/or whole-cell current-clamp recordings were obtained from dorsal horn neurons of the spinal cord under visual guidance on an Olympus BX51WI upright, fixed stage microscope equipped with infrared differential interference contrast (IR-DIC) and fluorescence optics (Olympus, Pittsburgh, PA). The aCSF used for simultaneous Ca2+ imaging and electrophysiological recording consisted of (in mM): 124 NaCl, 3 KCl, 2 CaCl2, 1.3 MgCl2, 1.4 NaH2PO4, 26 NaHCO3, and 11 glucose (pH 7.15–7.3); osmolality 290–310 mOsm/kg. Recording pipettes with open resistance of 2–5 MΩ were pulled from borosilicate glass capillaries with 0.45 mm wall thickness (King precision Glass, Claremont, CA). Seal resistance was 1–5 GΩ and, for whole-cell recordings, series resistance was 5–25 MΩ, uncompensated. Patch pipettes were filled with (in mM): 130 K+-gluconate, 1 NaCl, 5 EGTA, 1 MgCl2, 1 CaCl2, 3 KOH, 4 ATP; pH = 7.2-7.4. Neural activity was recorded using a Multiclamp 700B patch-clamp amplifier (Axon Instruments, Sunnyvale, CA), low-pass filtered at 5 kHz, acquired and with a Digidata 1440A digitizer and pClamp 10.3 software. Action potentials and whole-cell Na+ currents were analyzed off-line on a PC-style computer with pCLAMP programs (Axon Instruments) or Minianalysis 6.0.3 (Synaptosoft, Fort Lee, NJ). For whole-cell recordings, APs were recorded at rest in current-clamp mode. A 2-fold increase in firing frequency was used as minimum threshold for responses to glutamate stimulation.

          For electrophysiology studies, chemical stimulation of neurons in the dorsal horn was made by pressure applying L-glutamate (50 mM; 10–200 ms; dissolved in aCSF) through a glass pipette (∼10 μm tip diameter) positioned at the surface of the slice (Picospritzer, Parker-Hannefin, Fairfield, NJ, USA). Glutamate was applied directly over the recoded cell to evoke unclamped, rapid APs and/or Ca2+ response. Slices were positioned such that aCSF flowed dorsolaterally, away from the dorsal horn to minimize possible direct effects of glutamate on other neurons in the slice during recording.

          Spared nerve injury (SNI) model

          Mice were anesthetized with isoflurane (5% induction, 3% maintenance). The left hind-leg area was shaved and wiped clean with alcohol and an incision was made in the skin at the level of the trifurcation of the sciatic nerve. The overlying muscles were retracted, exposing the common peroneal, tibial, and sural nerves. Common peroneal and tibial nerves were transected. Care was taken to avoid touching or stretching the sural branch. The muscle was sutured with absorbable 6–0 sutures (Ethicon, Somerville, NJ) and the wound was closed with 9-mm metal clips. Sham surgery was produced by skin incision at the level of the trifurcation, and by exposing but not touching the sciatic branches.

          Behavioral tests

          Tactile threshold was assessed with an incremental series of eight von Frey filaments of logarithmic stiffness (Stoelting, Inc., Wood Dale, IL; approximately 0.008–6.0 g). The 50% withdrawal threshold was determined using Dixon’s up–down method, modified by Chaplan et al. [79]. First, an intermediate von Frey hair (0.16 g) was applied perpendicular to the hind-paw surface with sufficient force to cause a slight bending of the filament. In case of a positive response (rapid withdrawal of the paw within 3 s), the next smaller filament was tested. In case of a negative response, the next larger filament was tested.

          Chemicals

          Fura-2 AM, Pluronic F-127 and Sulforhodamine 101 (SR-101) were purchased from Invitrogen (Carlsbad, CA). Glutamate was purchased from Sigma (St. Louis, MO). CNQX, GYKI 52466, AP-5, UBP-301, UBP-310 and AIDA were from Tocris Bioscience (Ellisville, MO).

          Statistical Analysis

          Outcomes were described for the experimental conditions using means ± SEM. For each glutamate-evoked response, a sample of cells was obtained from each slice and was averaged as replicates. Data were analyzed using GraphPad Prism 5 software (GraphPad Software, San Diego, CA). One-way ANOVA (with repeated measures where applicable) was used and Dunnett’s multiple comparison test was run (unless indicated otherwise) to determine significance compared to vehicle. For SNI vs. sham experiments statistical tests were performed using SAS v9.3 (Cary, NC). Slices were treated with different concentrations. For each concentration and slice, the cells were treated as replicates and values for the cells were averaged. A repeated measures ANOVA was implemented with experimental condition (SNI and sham) as the between factor and concentration (0.03, 0.1, 0.3 and 1 mM) as the within factor. Pairwise comparisons were implemented using Bonferonni adjustments.

          Declarations

          Acknowledgements

          Supported by R01NS45954 (BKT), R01DK080901 (BNS), and the Applied Statistics Lab and the Center for Clinical and Translational Science (CCTS) at the University of Kentucky. The CCTS is supported by NCRR UL1RR033173. We would also like to thank Stephanie E. Edelmann and Gregory I. Frolenkov for graciously providing animals for electrophysiological studies.

          Authors’ Affiliations

          (1)
          Department of Physiology, School of Medicine, University of Kentucky Medical Center

          References

          1. Latremoliere A, Woolf CJ: Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10: 895–926. 10.1016/j.jpain.2009.06.012PubMed CentralView ArticlePubMed
          2. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN: Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 2006, 26: 1281–1292. 10.1523/JNEUROSCI.3388-05.2006View ArticlePubMed
          3. Antal M, Fukazawa Y, Eordogh M, Muszil D, Molnar E, Itakura M, Takahashi M, Shigemoto R: Numbers, densities, and colocalization of AMPA- and NMDA-type glutamate receptors at individual synapses in the superficial spinal dorsal horn of rats. J Neurosci 2008, 28: 9692–9701. 10.1523/JNEUROSCI.1551-08.2008PubMed CentralView ArticlePubMed
          4. Alvarez FJ, Villalba RM, Carr PA, Grandes P, Somohano PM: Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. J Comp Neurol 2000, 422: 464–487. 10.1002/1096-9861(20000703)422:3<464::AID-CNE11>3.0.CO;2-#View ArticlePubMed
          5. Carvalho AL, Duarte CB, Carvalho AP: Regulation of AMPA receptors by phosphorylation. Neurochem Res 2000, 25: 1245–1255. 10.1023/A:1007644128886View ArticlePubMed
          6. Chen BS, Roche KW: Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53: 362–368. 10.1016/j.neuropharm.2007.05.018PubMed CentralView ArticlePubMed
          7. Lau CG, Zukin RS: NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007, 8: 413–426.View ArticlePubMed
          8. Ruscheweyh R, Sandkuhler J: Long-range oscillatory Ca2+ waves in rat spinal dorsal horn. Eur J Neurosci 2005, 22: 1967–1976. 10.1111/j.1460-9568.2005.04393.xView ArticlePubMed
          9. Schoffnegger D, Ruscheweyh R, Sandkuhler J: Spread of excitation across modality borders in spinal dorsal horn of neuropathic rats. Pain 2008, 135: 300–310. 10.1016/j.pain.2007.12.016View ArticlePubMed
          10. Luo C, Seeburg PH, Sprengel R, Kuner R: Activity-dependent potentiation of calcium signals in spinal sensory networks in inflammatory pain states. Pain 2008, 140: 358–367. 10.1016/j.pain.2008.09.008View ArticlePubMed
          11. Ghosh A, Greenberg ME: Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995, 268: 239–247. 10.1126/science.7716515View ArticlePubMed
          12. Barres BA: New roles for glia. J Neurosci 1991, 11: 3685–3694.PubMed
          13. Nimmerjahn A, Kirchhoff F, Kerr JN, Helmchen F: Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo. Nat Methods 2004, 1: 31–37. 10.1038/nmeth706View ArticlePubMed
          14. Kafitz KW, Meier SD, Stephan J, Rose CR: Developmental profile and properties of sulforhodamine 101–Labeled glial cells in acute brain slices of rat hippocampus. J Neurosci Methods 2008, 169: 84–92. 10.1016/j.jneumeth.2007.11.022View ArticlePubMed
          15. Daulhac L, Mallet C, Courteix C, Etienne M, Duroux E, Privat AM, Eschalier A, Fialip J: Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Mol Pharmacol 2006, 70: 1246–1254. 10.1124/mol.106.025478View ArticlePubMed
          16. Yashpal K, Fisher K, Chabot JG, Coderre TJ: Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Pain 2001, 94: 17–29. 10.1016/S0304-3959(01)00337-2View ArticlePubMed
          17. Burton AW, Lee DH, Saab C, Chung JM: Preemptive intrathecal ketamine injection produces a long-lasting decrease in neuropathic pain behaviors in a rat model. Reg Anesth Pain Med 1999, 24: 208–213.PubMed
          18. Yoshimura M, Yonehara N: Alteration in sensitivity of ionotropic glutamate receptors and tachykinin receptors in spinal cord contribute to development and maintenance of nerve injury-evoked neuropathic pain. Neurosci Res 2006, 56: 21–28. 10.1016/j.neures.2006.04.015View ArticlePubMed
          19. Gwak YS, Kang J, Leem JW, Hulsebosch CE: Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats. J Neurosci Res 2007, 85: 2352–2359. 10.1002/jnr.21379View ArticlePubMed
          20. Chaplan SR, Pogrel JW, Yaksh TL: Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994, 269: 1117–1123.PubMed
          21. Fukuizumi T, Ohkubo T, Kitamura K: Spinal sensitization mechanism in vincristine-induced hyperalgesia in mice. Neurosci Lett 2003, 343: 89–92. 10.1016/S0304-3940(03)00332-XView ArticlePubMed
          22. Matthews EA, Dickenson AH: Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 2001, 415: 141–149. 10.1016/S0014-2999(01)00812-3View ArticlePubMed
          23. Matthews EA, Dickenson AH: Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001, 92: 235–246. 10.1016/S0304-3959(01)00255-XView ArticlePubMed
          24. Voitenko NV, Kruglikov IA, Kostyuk EP, Kostyuk PG: Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons. Neuroscience 2000, 95: 519–524.View ArticlePubMed
          25. Yaksh TL: Calcium channels as therapeutic targets in neuropathic pain. J Pain 2006, 7: S13-S30.View ArticlePubMed
          26. Lee MJ, Shin TJ, Lee JE, Choo H, Koh HY, Chung HJ, Pae AN, Lee SC, Kim HJ: KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models. Pharmacol Biochem Behav 2010, 97: 198–204. 10.1016/j.pbb.2010.07.018View ArticlePubMed
          27. Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288: 1765–1769. 10.1126/science.288.5472.1765View ArticlePubMed
          28. Larsson M: Ionotropic glutamate receptors in spinal nociceptive processing. Mol Neurobiol 2009, 40: 260–288. 10.1007/s12035-009-8086-8View ArticlePubMed
          29. Sandkuhler J: Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 2009, 89: 707–758. 10.1152/physrev.00025.2008View ArticlePubMed
          30. Larsson M, Broman J: Synaptic Plasticity and Pain: Role of Ionotropic Glutamate Receptors. Neuroscientist 2011,17(3):256–273. 10.1177/1073858409349913View ArticlePubMed
          31. Nagy GG, Al-Ayyan M, Andrew D, Fukaya M, Watanabe M, Todd AJ: Widespread expression of the AMPA receptor GluR2 subunit at glutamatergic synapses in the rat spinal cord and phosphorylation of GluR1 in response to noxious stimulation revealed with an antigen-unmasking method. J Neurosci 2004, 24: 5766–5777. 10.1523/JNEUROSCI.1237-04.2004View ArticlePubMed
          32. Nagy GG, Watanabe M, Fukaya M, Todd AJ: Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur J Neurosci 2004, 20: 3301–3312. 10.1111/j.1460-9568.2004.03798.xView ArticlePubMed
          33. Hegarty DM, Mitchell JL, Swanson KC, Aicher SA: Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn. Brain Res 2007, 1184: 149–159.PubMed CentralView ArticlePubMed
          34. Lee CJ, Kong H, Manzini MC, Albuquerque C, Chao MV, MacDermott AB: Kainate receptors expressed by a subpopulation of developing nociceptors rapidly switch from high to low Ca2+ permeability. J Neurosci 2001, 21: 4572–4581.PubMed
          35. Guo W, Zou S, Tal M, Ren K: Activation of spinal kainate receptors after inflammation: behavioral hyperalgesia and subunit gene expression. Eur J Pharmacol 2002, 452: 309–318. 10.1016/S0014-2999(02)02333-6View ArticlePubMed
          36. Pitcher MH, Ribeiro-da-Silva A, Coderre TJ: Effects of inflammation on the ultrastructural localization of spinal cord dorsal horn group I metabotropic glutamate receptors. J Comp Neurol 2007, 505: 412–423. 10.1002/cne.21506View ArticlePubMed
          37. Wang YJ, Tseng GF: Spinal axonal injury transiently elevates the level of metabotropic glutamate receptor 5, but not 1, in cord-projection central neurons. J Neurotrauma 2004, 21: 479–489. 10.1089/089771504323004629View ArticlePubMed
          38. Miura M, Watanabe M, Offermanns S, Simon MI, Kano M: Group I metabotropic glutamate receptor signaling via Galpha q/Galpha 11 secures the induction of long-term potentiation in the hippocampal area CA1. J Neurosci 2002, 22: 8379–8390.PubMed
          39. Azkue JJ, Liu XG, Zimmermann M, Sandkuhler J: Induction of long-term potentiation of C fibre-evoked spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors. Pain 2003, 106: 373–379. 10.1016/j.pain.2003.08.007View ArticlePubMed
          40. Derjean D, Bertrand S, Le Masson G, Landry M, Morisset V, Nagy F: Dynamic balance of metabotropic inputs causes dorsal horn neurons to switch functional states. Nat Neurosci 2003, 6: 274–281. 10.1038/nn1016View ArticlePubMed
          41. Lefebvre C, Fisher K, Cahill CM, Coderre TJ: Evidence that DHPG-induced nociception depends on glutamate release from primary afferent C-fibres. Neuroreport 2000, 11: 1631–1635. 10.1097/00001756-200006050-00007View ArticlePubMed
          42. Soliman AC, Yu JS, Coderre TJ: mGlu and NMDA receptor contributions to capsaicin-induced thermal and mechanical hypersensitivity. Neuropharmacology 2005, 48: 325–332. 10.1016/j.neuropharm.2004.10.014View ArticlePubMed
          43. Young MR, Fleetwood-Walker SM, Dickinson T, Blackburn-Munro G, Sparrow H, Birch PJ, Bountra C: Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Res 1997, 777: 161–169.View ArticlePubMed
          44. Young MR, Fleetwood-Walker SM, Mitchell R, Munro FE: Evidence for a role of metabotropic glutamate receptors in sustained nociceptive inputs to rat dorsal horn neurons. Neuropharmacology 1994, 33: 141–144. 10.1016/0028-3908(94)90109-0View ArticlePubMed
          45. Flynn JR, Brichta AM, Galea MP, Callister RJ, Graham BA: A horizontal slice preparation for examining the functional connectivity of dorsal column fibres in mouse spinal cord. J Neurosci Methods 2011, 200: 113–120. 10.1016/j.jneumeth.2011.06.017View ArticlePubMed
          46. Cheng LZ, Lu N, Zhang YQ, Zhao ZQ: Ryanodine receptors contribute to the induction of nociceptive input-evoked long-term potentiation in the rat spinal cord slice. Mol Pain 2010, 6: 1. 10.1186/1744-8069-6-1PubMed CentralView ArticlePubMed
          47. Jakowec MW, Yen L, Kalb RG: In situ hybridization analysis of AMPA receptor subunit gene expression in the developing rat spinal cord. Neuroscience 1995, 67: 909–920. 10.1016/0306-4522(95)00094-YView ArticlePubMed
          48. Brown KM, Wrathall JR, Yasuda RP, Wolfe BB: Quantitative measurement of glutamate receptor subunit protein expression in the postnatal rat spinal cord. Brain Res Dev Brain Res 2002, 137: 127–133.View ArticlePubMed
          49. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, Sevarino KA: Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 1995, 15: 6498–6508.PubMed
          50. Jakowec MW, Fox AJ, Martin LJ, Kalb RG: Quantitative and qualitative changes in AMPA receptor expression during spinal cord development. Neuroscience 1995, 67: 893–907. 10.1016/0306-4522(95)00026-FView ArticlePubMed
          51. Kalb RG, Lidow MS, Halsted MJ, Hockfield S: N-methyl-D-aspartate receptors are transiently expressed in the developing spinal cord ventral horn. Proc Natl Acad Sci U S A 1992, 89: 8502–8506. 10.1073/pnas.89.18.8502PubMed CentralView ArticlePubMed
          52. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH: Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12: 529–540. 10.1016/0896-6273(94)90210-0View ArticlePubMed
          53. Portera-Cailliau C, Price DL, Martin LJ: N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J Neurochem 1996, 66: 692–700.View ArticlePubMed
          54. Torsney C, MacDermott AB: Disinhibition opens the gate to pathological pain signaling in superficial neurokinin 1 receptor-expressing neurons in rat spinal cord. J Neurosci 2006, 26: 1833–1843. 10.1523/JNEUROSCI.4584-05.2006View ArticlePubMed
          55. Heinke B, Balzer E, Sandkuhler J: Pre- and postsynaptic contributions of voltage-dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci 2004, 19: 103–111. 10.1046/j.1460-9568.2003.03083.xView ArticlePubMed
          56. McDougal DH, Hermann GE, Rogers RC: Vagal afferent stimulation activates astrocytes in the nucleus of the solitary tract via AMPA receptors: evidence of an atypical neural-glial interaction in the brainstem. J Neurosci 2011, 31: 14037–14045. 10.1523/JNEUROSCI.2855-11.2011PubMed CentralView ArticlePubMed
          57. Winship IR, Plaa N, Murphy TH: Rapid astrocyte calcium signals correlate with neuronal activity and onset of the hemodynamic response in vivo. J Neurosci 2007, 27: 6268–6272. 10.1523/JNEUROSCI.4801-06.2007View ArticlePubMed
          58. Zur Nieden R, Deitmer JW: The role of metabotropic glutamate receptors for the generation of calcium oscillations in rat hippocampal astrocytes in situ. Cereb Cortex 2006, 16: 676–687.View ArticlePubMed
          59. Kirischuk S, Verkhratsky A: [Ca2+]i recordings from neural cells in acutely isolated cerebellar slices employing differential loading of the membrane-permeant form of the calcium indicator fura-2. Pflugers Arch 1996, 431: 977–983.View ArticlePubMed
          60. Mayer ML, Westbrook GL, Guthrie PB: Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984, 309: 261–263. 10.1038/309261a0View ArticlePubMed
          61. Watanabe M, Mishina M, Inoue Y: Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J Comp Neurol 1994, 345: 314–319. 10.1002/cne.903450212View ArticlePubMed
          62. Hartwick AT, Hamilton CM, Baldridge WH: Glutamatergic calcium dynamics and deregulation of rat retinal ganglion cells. J Physiol 2008, 586: 3425–3446. 10.1113/jphysiol.2008.154609PubMed CentralView ArticlePubMed
          63. Engelman HS, Allen TB, MacDermott AB: The distribution of neurons expressing calcium-permeable AMPA receptors in the superficial laminae of the spinal cord dorsal horn. J Neurosci 1999, 19: 2081–2089.PubMed
          64. Youn DH, Voitenko N, Gerber G, Park YK, Galik J, Randic M: Altered long-term synaptic plasticity and kainate-induced Ca2+ transients in the substantia gelatinosa neurons in GLU(K6)-deficient mice. Brain Res Mol Brain Res 2005, 142: 9–18.View ArticlePubMed
          65. Urban L, Thompson SW, Dray A: Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci 1994, 17: 432–438. 10.1016/0166-2236(94)90018-3View ArticlePubMed
          66. Fang L, Wu J, Zhang X, Lin Q, Willis WD: Increased phosphorylation of the GluR1 subunit of spinal cord alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor in rats following intradermal injection of capsaicin. Neuroscience 2003, 122: 237–245. 10.1016/S0306-4522(03)00526-8View ArticlePubMed
          67. Esteban JA, Shi SH, Wilson C, Nuriya M, Huganir RL, Malinow R: PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci 2003, 6: 136–143. 10.1038/nn997View ArticlePubMed
          68. Zou X, Lin Q, Willis WD: Effect of protein kinase C blockade on phosphorylation of NR1 in dorsal horn and spinothalamic tract cells caused by intradermal capsaicin injection in rats. Brain Res 2004, 1020: 95–105. 10.1016/j.brainres.2004.06.017View ArticlePubMed
          69. Brenner GJ, Ji RR, Shaffer S, Woolf CJ: Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci 2004, 20: 375–384. 10.1111/j.1460-9568.2004.03506.xView ArticlePubMed
          70. Ultenius C, Linderoth B, Meyerson BA, Wallin J: Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 2006, 399: 85–90. 10.1016/j.neulet.2006.01.018View ArticlePubMed
          71. Chen L, Huang LY: Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992, 356: 521–523. 10.1038/356521a0View ArticlePubMed
          72. Scotland PE, Coderre TJ: Enhanced 3,5-dihydroxyphenylglycine-induced sustained nociceptive behaviors in rats with neuropathy or chronic inflammation. Behav Brain Res 2007, 184: 150–156. 10.1016/j.bbr.2007.07.003View ArticlePubMed
          73. Isaac JT, Ashby MC, McBain CJ: The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 2007, 54: 859–871. 10.1016/j.neuron.2007.06.001View ArticlePubMed
          74. Liu SJ, Zukin RS: Ca2 + −permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci 2007, 30: 126–134. 10.1016/j.tins.2007.01.006View ArticlePubMed
          75. Park JS, Voitenko N, Petralia RS, Guan X, Xu JT, Steinberg JP, Takamiya K, Sotnik A, Kopach O, Huganir RL, Tao YX: Persistent inflammation induces GluR2 internalization via NMDA receptor-triggered PKC activation in dorsal horn neurons. J Neurosci 2009, 29: 3206–3219. 10.1523/JNEUROSCI.4514-08.2009PubMed CentralView ArticlePubMed
          76. Park JS, Yaster M, Guan X, Xu JT, Shih MH, Guan Y, Raja SN, Tao YX: Role of spinal cord alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in complete Freund's adjuvant-induced inflammatory pain. Mol Pain 2008, 4: 67. 10.1186/1744-8069-4-67PubMed CentralView ArticlePubMed
          77. Bardoni R, Ghirri A, Zonta M, Betelli C, Vitale G, Ruggieri V, Sandrini M, Carmignoto G: Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn. J Physiol 2010, 588: 831–846. 10.1113/jphysiol.2009.180570PubMed CentralView ArticlePubMed
          78. Balasubramanyan S, Stemkowski PL, Stebbing MJ, Smith PA: Sciatic chronic constriction injury produces cell-type-specific changes in the electrophysiological properties of rat substantia gelatinosa neurons. J Neurophysiol 2006, 96: 579–590. 10.1152/jn.00087.2006View ArticlePubMed
          79. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53: 55–63. 10.1016/0165-0270(94)90144-9View ArticlePubMed

          Copyright

          © Doolen et al.; licensee BioMed Central Ltd. 2012

          This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

          Advertisement